Evaluation of on-site cytology during EBUS-TBNA correlates with final pathology, suggesting enhanced outcomes for diagnosis.
ROSE during EBUS-TBNA yielded high sensitivity and overall accuracy, demonstrated strong sample adequacy, and showed substantial concordance with the final pathology. Optimizing the number of passes and considering LN size can enhance adequacy, and recognizing the limitations of cytological subtyping and potential observer variability is essential for multidisciplinary decision-making.
No takes yet. Share an insight, caveat, or question.
Karataş et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: